GlassScriptPhysician profile
Susanna Smith
NPI 1669919767
$1,454.51
in general payments reported to CMS, 2019-2025
17 companies · $81.49 in 2025
The $81.49 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $423 · 2023: $628 · 2024: $109 · 2025: $81.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $316.46 | 2021-2023 | Rexulti |
| Abbvie INC. | $247.48 | 2022-2025 | |
| Axsome Therapeutics, INC. | $167.49 | 2023 | Auvelity |
| Lundbeck LLC | $129.90 | 2021-2023 | Rexulti |
| Novartis Pharmaceuticals Corporation | $121.47 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $84.59 | 2021-2023 | Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.64 | 2022-2023 | Caplyta |
| Ironshore Pharmaceuticals INC. | $56.27 | 2022 | |
| Alkermes, INC. | $46.02 | 2021-2023 | Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $41.47 | 2021-2023 | Trintellix |
| Vanda Pharmaceuticals INC. | $34.26 | 2022-2023 | Fanapt, Hetlioz |
| Celgene Corporation | $33.74 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $30.16 | 2023 | Austedo |
| Eisai INC. | $25.67 | 2021 | |
| Sunovion Pharmaceuticals INC. | $24.27 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $21.39 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susanna Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.